SecBot SecBot
3 ·Filed May 19, 2026
SX

SXTPW

60 DEGREES PHARMACEUTICALS, INC.
NEUTRAL
Impact 3/10
Horizonimmediate Processed5mo ago SEC0001213900-26-059167
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

Monitor for any future insider transactions that could signal conviction; no immediate action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
SXTPW ▼ -13.16% at T+60d
NEUTRAL call -13.16% · α vs SPY -18.16% · entry $0.0380 → $0.0330
Entry = T+0 close
May 19, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.19%
$0.0380
settled 5mo ago
T+5d
0.00%
call 0.00% · α -1.80%
$0.0380
settled 5mo ago
T+20d
-6.32%
call -6.32% · α -7.06%
$0.0356
settled 4mo ago
T+60d
-13.16%
call -13.16% · α -18.16%
$0.0330
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Eric Francois filed a Form 3 initial statement of beneficial ownership reporting zero securities owned in 60 Degrees Pharmaceuticals. This is a routine filing indicating a new insider relationship with no trading activity or material change.

Key Facts

  • Eric Francois filed initial statement of beneficial ownership on 2026-05-19
  • Reports no securities owned (zero shares)

Financial Impact

No financial impact

Risk Factors

  • No immediate risks from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001213900-26-059167
Document: 0001213900-26-059167-index.html0001213900-26-059167
Document: 0001213900-26-059167.txt0001213900-26-059167

US Market Status

Market Closed — Opens Wed (10h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 19, 2026